Ex-PRESS better than trabeculectomy

Article

The Ex-PRESS implant appears to be as effective as trabeculectomy, furthermore it reduces postoperative compliance issues and seems to be safer, according to a paper presented at this year's World Glaucoma Congress held in Singapore.

The Ex-PRESS implant appears to be as effective as trabeculectomy, furthermore it reduces postoperative compliance issues and seems to be safer, according to a paper presented at this year's World Glaucoma Congress held in Singapore.

In a prospective clinical study, 34 pseudophakic glaucomatous subjects, not controlled by topical therapy, were randomized into two groups to receive either the Ex-PRESS implant or undergo trabeculectomy. All subjects had a postoperative intraocular pressure (IOP) measurement over 24 mmHg.

In the Ex-PRESS group (17 subjects), preoperative IOP was 26±2.18 mmHg and in the trabeculectomy group (17 subjects) it was 26.7±1.98 mmHg. At one week follow-up the mean IOP had fallen to 14±4.2 mmHg (p=<0.001) and 15.4±3.6 mmHg (P=<0.001), in the Ex-PRESS and trabeculectomy group, respectively. In the Ex-PRESS group, two eyes required an anterior chamber (AC) viscoelastic refilling for AC flattening. In the trabeculectomy group, four eyes had choroidal detachment, three eyes had AC flattening requiring an AC refilling and two eyes had hyphema.

It was concluded that, not only is the Ex-PRESS as effective as trabeculectomy in lowering IOP, it is also safer.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
© 2025 MJH Life Sciences

All rights reserved.